Substituted estratriene derivatives as 17BETA HSD inhibitors

Substituted estratriene compounds of formula (I) useful in therapy, especially in the treatment or inhibition of a steroid hormone dependent disorder requiring the inhibition of a 17β-hydroxysteroid dehydrogenase (17β-HSD) type 1, type 2 and/or type 3 enzyme, as well as their salts, pharmaceutical c...

Full description

Saved in:
Bibliographic Details
Main Authors Messinger, Josef, Schoen, Uwe, Thole, Heinrich-Hubert, Husen, Bettina, Koskimies, Pasi, Unkila, Mikko
Format Patent
LanguageEnglish
Published 16.10.2012
Online AccessGet full text

Cover

More Information
Summary:Substituted estratriene compounds of formula (I) useful in therapy, especially in the treatment or inhibition of a steroid hormone dependent disorder requiring the inhibition of a 17β-hydroxysteroid dehydrogenase (17β-HSD) type 1, type 2 and/or type 3 enzyme, as well as their salts, pharmaceutical compositions containing such compounds and processes for preparing such compounds.